Valtensam Comp 10 mg/ 160 mg/ 12,5 mg Filmdragerad tablett

Država: Švedska

Jezik: švedski

Izvor: Läkemedelsverket (Medical Products Agency)

Kupi sada

Svojstava lijeka Svojstava lijeka (SPC)
16-04-2020

Aktivni sastojci:

amlodipinbesilat; hydroklortiazid; valsartan

Dostupno od:

Teva B.V.

ATC koda:

C09DX01

INN (International ime):

amlodipinbesilat; hydrochlorothiazide; valsartan

Doziranje:

10 mg/ 160 mg/ 12,5 mg

Farmaceutski oblik:

Filmdragerad tablett

Sastav:

laktosmonohydrat Hjälpämne; valsartan 160 mg Aktiv substans; hydroklortiazid 12,5 mg Aktiv substans; amlodipinbesilat 13,86 mg Aktiv substans

Tip recepta:

Receptbelagt

Proizvod sažetak:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter

Status autorizacije:

Avregistrerad

Datum autorizacije:

2020-04-15

Svojstava lijeka

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Valtensam Comp 10 mg/160 mg/12.5 mg film-coated tablets
Valtensam Comp 5 mg/160 mg/25 mg film-coated tablets
Valtensam Comp 10 mg/160 mg/25 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each film-coated tablet contains amlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 12.5 mg of hydrochlorothiazide.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 5 mg
amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
Excipient(s) with known effect
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIL on
one side of the tablet.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIH on one
side of the tablet
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIT on
one side of the tablet.
2
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of essential hypertension as substitution therapy in adult
patients whose blood pressure is
adequately controlled on the combination of amlodipine, valsartan and
hydrochlorothiazide (HCT),

                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku engleski 12-08-2022
Svojstava lijeka Svojstava lijeka engleski 12-08-2022
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 27-05-2020